Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Savara, Inc. - Common Stock (NQ:SVRA)

3.470 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 3.470
Bid (Size) 3.400 (1)
Ask (Size) 3.650 (12)
Prev. Close 3.470
Today's Range 3.470 - 3.470
52wk Range 1.890 - 4.295
Shares Outstanding 114,066,080
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Savara Inc. INVESTOR ALERT: Kirby McInerney LLP Reminds Savara Inc. Investors of Looming Lead Plaintiff Deadline in Class Action Lawsuit
From Kirby McInerney LLP
Via GlobeNewswire
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Savara Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action– SVRA
From The Rosen Law Firm PA
Via GlobeNewswire

Performance

YTD
+13.0%
+13.0%
1 Month
-9.9%
-9.9%
3 Month
+46.4%
+46.4%
6 Month
+26.6%
+26.6%
1 Year
-8.2%
-8.2%

More News

Read More
SVRA DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Savara
From Faruqi & Faruqi LLP
Via GlobeNewswire
Savara Inc. INVESTOR ALERT: Kirby McInerney LLP Reminds Savara Inc. Investors of Looming Lead Plaintiff Deadline in Class Action Lawsuit
From Kirby McInerney LLP
Via GlobeNewswire
SAVARA CLASS ACTION REMINDER: Bragar Eagel & Squire, P.C. Reminds Investors of the November 7th Deadline in The Savara Class Action Lawsuit
From Bragar Eagel & Squire
Via GlobeNewswire
Savara Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before November 7, 2025 to Discuss Your Rights - SVRA
Via NewMediaWire
Topics Fraud Lawsuit
Savara Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before November 7, 2025 to Discuss Your Rights - SVRA
Via TheNewswire.com
Topics Fraud Lawsuit
SVRA INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Savara
From Faruqi & Faruqi LLP
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Urges Investors of Tronox, Savara, Quantum, or Fly-E to Contact the Firm Regarding the Filed Class Action Lawsuits
From Bragar Eagel & Squire
Via GlobeNewswire
Savara Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - SVRA
Via NewMediaWire
Topics Fraud Lawsuit
Savara Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - SVRA
Via TheNewswire.com
Topics Fraud Lawsuit
SVRA NOTICE: Savara Inc. Investors Urged to Contact Kirby McInerney LLP About Securities Fraud Lawsuit
From Kirby McInerney LLP
Via GlobeNewswire
Savara Announces Encore Presentations of Results From the Phase 3 IMPALA-2 Clinical Trial of Molgramostim Inhalation Solution (Molgramostim) in Patients with Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at CHEST 2025
From Savara Inc.
Via Business Wire
Class Action Filed Against Savara Inc. (SVRA) Seeking Recovery for Investors - Contact Levi & Korsinsky
Via NewMediaWire
Topics Fraud Lawsuit
Class Action Filed Against Savara Inc. (SVRA) Seeking Recovery for Investors - Contact Levi & Korsinsky
Via TheNewswire.com
Topics Fraud Lawsuit
Bragar Eagel & Squire, P.C. Reminds Investors of Tronox, Savara, Quantum, and Fly-E that Class Action Lawsuits Have Been Filed and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Levi & Korsinsky Reminds Savara Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of November 7, 2025 - SVRA
Via NewMediaWire
Topics Fraud Lawsuit
Levi & Korsinsky Reminds Savara Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of November 7, 2025 - SVRA
Via TheNewswire.com
Topics Fraud Lawsuit
Savara Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - SVRA
Via NewMediaWire
Topics Fraud Lawsuit
Savara Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - SVRA
Via TheNewswire.com
Topics Fraud Lawsuit
Savara Presents New Data From the Phase 3 IMPALA-2 Clinical Trial of Molgramostim Inhalation Solution (Molgramostim) in Patients With Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the European Respiratory Society (ERS) Congress 2025
From Savara Inc.
Via Business Wire
Investors in Savara Inc. Should Contact Levi & Korsinsky Before November 7, 2025 to Discuss Your Rights - SVRA
Via NewMediaWire
Topics Fraud Lawsuit
Investors in Savara Inc. Should Contact Levi & Korsinsky Before November 7, 2025 to Discuss Your Rights - SVRA
Via TheNewswire.com
Topics Fraud Lawsuit
Levi & Korsinsky Reminds Savara Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of November 7, 2025 - SVRA
Via NewMediaWire
Topics Fraud Lawsuit
Levi & Korsinsky Reminds Savara Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of November 7, 2025 - SVRA
Via TheNewswire.com
Topics Fraud Lawsuit

Frequently Asked Questions

Is Savara, Inc. - Common Stock publicly traded?
Yes, Savara, Inc. - Common Stock is publicly traded.
What exchange does Savara, Inc. - Common Stock trade on?
Savara, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Savara, Inc. - Common Stock?
The ticker symbol for Savara, Inc. - Common Stock is SVRA on the Nasdaq Stock Market
What is the current price of Savara, Inc. - Common Stock?
The current price of Savara, Inc. - Common Stock is 3.470
When was Savara, Inc. - Common Stock last traded?
The last trade of Savara, Inc. - Common Stock was at 10/08/25 04:00 PM ET
What is the market capitalization of Savara, Inc. - Common Stock?
The market capitalization of Savara, Inc. - Common Stock is 395.81M
How many shares of Savara, Inc. - Common Stock are outstanding?
Savara, Inc. - Common Stock has 396M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.